← 홈

ADC

167개 · ADC 1068 · Antibody 5456 · CGT 2744 · 다음 갱신 D-13 · 마지막 7월 13일

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 167개
ADCBiologicKing Abdullah International Med…Vedotin Plus AVD versus ABV…Phase 2

ABVD (ABVD)

Classical Hodgkin Lymphoma; Hodgkin Lymphoma (Category) · Hodgkin Lymphoma

#HodgkinLymphoma#ADC#Phase2#인기#항체약물접합체+5
효능 ORR 96%임상시험 52상태 ACTIVE
ADCBiologicSWOG Cancer Research NetworkVedotin, and BelinostatPhase 3

Pirtobrutinib (Pirtobrutinib)

Richter Syndrome; Transformed Chronic Lymphocytic Leukemia to Diffuse Large B-Cell Lymphoma · Chronic Lymphocytic Leukemia

#ChronicLymphocyticLeukemia#ADC#Phase3#인기#항체약물접합체+5
효능 ORR 66.4%임상시험 52상태 RECRUITING
ADCBiologicRochevedotin, rituximab, cycloph…Phase 2

Polatuzumab (Polatuzumab)

Diffuse Large B Cell Lymphoma (DLBCL); High Grade B Cell Lymphoma · Lymphoma

#Lymphoma#ADC#Phase2#인기#항체약물접합체+5
효능 ORR 100%임상시험 52상태 RECRUITING
ADCBiologicSeagenvedotin-containing regimen …Phase 2

SGN-35 (brentuximab vedotin, brentuximab vedotin (SGN-35))

Hodgkin's Lymphoma · Hodgkin's Lymphoma

#HodgkinsLymphoma#ADC#Phase2#인기#항체약물접합체+4
효능 ORR 89.5%임상시험 52상태 ACTIVE
ADCBiologicSeagenvedotin-containing regimen …Phase 2

Adcetris (Brentuximab vedotin, Brentuximab vedotin (Adcetris))

Anaplastic Large Cell Lymphoma, ALK-Positive · Anaplastic Large Cell Lymphoma, ALK-Posi

#AnaplasticLargeCellLymphomaALK-P#ADC#Phase2#인기#항체약물접합체+5
효능 ORR 89.5%임상시험 51상태 RECRUITING
ADCBiologicMedImmune LLCvedotin combined with cispl…Phase 2

DHAP (DHAP)

Diffuse Large B-Cell Lymphoma · FRα

#FR#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+4
효능 ORR 47.5%임상시험 48상태 ACTIVE
ADCBBiologicADC TherapeuticsthatPhase 2

Anti-CD19 Antibody-Drug Conjugate (Loncastuximab Tesirine, Loncastuximab Tesirine (Anti-CD19 Antibody-Drug Conjugate))

Diffuse Large B-Cell Lymphoma; High-grade B-cell Lymphoma (HGBCL) · CD19

#CD19#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+4
효능 ORR 94.1%임상시험 48상태 RECRUITING
ADCBiologicMillennium Pharmaceuticals, Inc.Vedotin or Other Standard T…Phase 3

Bexarotene (Bexarotene)

Primary Cutaneous Anaplastic Large Cell Lymphoma; Mycosis Fungoides · Primary Cutaneous Anaplastic Large Cell

#PrimaryCutaneousAnaplasticLargeC#ADC#Phase3#항체약물접합체#antibody-drug-conjugate+4
효능 ORR 54.7%임상시험 40상태 ACTIVE
ADCBiologicCelgenePhase 2

CC-220 (CC-220)

Lymphoma · Lymphoma, B-Cell

#LymphomaB-Cell#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+3
효능 ORR 71.4%임상시험 37상태 DISCONTINUED
ADCBiologicIncyte CorporationPhase 1

Parsaclisib (Parsaclisib)

Ann Arbor Stage II Diffuse Large B-Cell Lymphoma; Ann Arbor Stage II Follicular Lymphoma · Ann Arbor Stage II Diffuse Large B-Cell

#AnnArborStageIIDiffuseLargeB-Cel#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+3
효능 ORR 88.1%임상시험 34상태 RECRUITING
ADCBiologicstaleNanogen Pharmaceutical Biotechn…Phase 2

Neulasta (Neulasta)

Hodgkin Lymphoma; Anaplastic Large Cell Lymphoma · Hodgkin Lymphoma

#HodgkinLymphoma#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2
효능 ORR 7%임상시험 31상태 ACTIVE
ADCBiologicstaleCzech Lymphoma Study GroupPhase 2

Prednisone tablet (Prednisone tablet)

Lymphoma, T-Cell, Peripheral · Lymphoma, T-Cell, Peripheral

#LymphomaT-CellPeripheral#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+4
효능 ORR 16.8%임상시험 31상태 ACTIVE
ADCBiologicstalePharmacyclics LLC.Phase 3

Procarbazine Hydrochloride (Procarbazine Hydrochloride)

Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8 · Lugano Classification Limited Stage Hodg

#LuganoClassificationLimitedStage#ADC#Phase3#항체약물접합체#antibody-drug-conjugate+1
효능 ORR 1%임상시험 31상태 RECRUITING
ADCBiologicstaleSeagen Inc.Phase 2

SGN-35 (SGN-35)

Disease, Hodgkin; Lymphoma, Large-Cell, Anaplastic · Disease, Hodgkin

#DiseaseHodgkin#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+4
효능 ORR 89.5%임상시험 31상태 ACTIVE
ADCBiologicstaleTakedaPhase 1

TAK228 (TAK228)

Malignant Neoplasms Stated as Primary Lymphoid Haematopoietic; Classical Hodgkin Lymphoma · CD30

#CD30#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+3
효능 ORR 18.4%임상시험 31상태 DISCONTINUED
ADCBiologicstaleMylan Pharmaceuticals IncPhase 1

Verapamil (Verapamil)

Recurrent Hodgkin Lymphoma; Refractory Hodgkin Lymphoma · FRα

#FR#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+3
임상시험 31상태 ACTIVE
ADCBiologicstaleSWOG Cancer Research NetworkPhase 2

Velban (Vinblastine, Vinblastine (Velban))

Anaplastic Large Cell Lymphoma, ALK-Positive · Anaplastic Large Cell Lymphoma, ALK-Posi

#AnaplasticLargeCellLymphomaALK-P#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+3
효능 ORR 96%임상시험 31상태 RECRUITING
ADCBiologicstaleSeagen Inc.Phase 2

Adriamycin, vinblastine, and dacarbazine (Adriamycin, vinblastine, and dacarbazine)

Hodgkin Lymphoma · Hodgkin Lymphoma

#HodgkinLymphoma#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1
효능 ORR 96%임상시험 30상태 ACTIVE
ADCBiologicstaleEisai Inc.Phase 2

DOC Group B (DOC Group B)

Non-hodgkin Lymphoma; Hodgkin Lymphoma · Non-hodgkin Lymphoma

#Non-hodgkinLymphoma#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2
임상시험 30상태 RECRUITING
ADCBiologicstaleVerastem, Inc.Phase 2

Defactinib (Defactinib)

Advanced Lymphoma; Advanced Malignant Solid Neoplasm · FRα

#FR#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+3
효능 ORR 3.2%임상시험 30상태 RECRUITING

3 / 9 페이지

← 이전다음 →